congress

Showing 7 posts of 7 posts found.

5369645453_2a0fbd2a9d_b

US lawmakers call for FDA office in Israel

November 26, 2019
Manufacturing and Production FDA, Golan Heights, Israel FDA, Netanyahu, Trump, USA, congress, israel

A bipartisan group of 21 US members of Congress has called for the establishment of an FDA office in Israel, …

Pharma boosts lobby spending in first quarter of 2019

April 24, 2019
Research and Development PhRMA, Trump, USA, congress, lobbying, lobbyists, pharma

The Pharmaceutical Research and Manufacturers of America (PhRMA) trade lobbyists have spent near record levels on lobbying in the first …

35482508871_5eabae9691_z

US Lawmaker launches investigation into pharma pricing practices

January 15, 2019
Manufacturing and Production Bernie Sanders, Elijah cummings, congress, pharma, pricing, us politics

Congressman Elijah Cummings has launched an investigation into pharmaceutical pricing practices.The representative for Maryland’s 7th congressional district, on Monday requested …

rep

US Congressman arrested over insider trading in biopharma firm

August 9, 2018
Research and Development, Sales and Marketing Chris Collins, Innate, Innate Immunotherapeutics, US, congress, multiple sclerosis, pharma

A Republican Congressman has been arrested by the FBI over on charges of insider trading with shares in Australian biopharmaceutical …

barack-obama-1174489_960_720

Obama seals $6.3 billion 21st Century Cures Act

December 14, 2016
Medical Communications, Research and Development Biden, Obama, US, congress

President Barack Obama put pen to paper on the 21st Century Cures Act on 13 December, which commits to investing …

mylan_plus_hero_720x510

Mylan latest target of US anger on drug pricing with EpiPen price increase

August 24, 2016
Research and Development, Sales and Marketing Mylan, US, congress, controversy, epipen, price gouging, price increase

The US congress is again subjecting the pharmaceutical industry to heavy scrutiny over drug pricing policies with Mylan its latest …

Shkreli hearing

Big pharma answers tough questions at US drug pricing hearing

February 5, 2016
Medical Communications Drug pricing, FDA, Martin Shkreli, Senate, Turing Pharmaceuticals, US, Valeant, congress

Pharmaceutical industry executives came under intense scrutiny at a Congressional hearing in the US as the debate over the spiralling …

Latest content